Important note: Information in this article was accurate in 1985. The state of the art may have changed since the publication date.
Associated Press - February 9, 1985
The vaccine is the first ever developed to prevent infection with retroviruses, an unusual class of viruses only recently found to be important in human disease.
But researchers last year identified another human retrovirus that appears to cause AIDS, acquired immune deficiency syndrome.
The vaccine "is an important step forward," said Dr. William Hardy, head of the laboratory of veterinary oncology at Memorial Sloan-Kettering Cancer Center in New York.
The problem with AIDS, however, is that the virus appears to change as it infects, possibly confounding the development of a vaccine, Dr. Hardy said.
850209
AP850202
Copyright © 1985 - Associated Press. Reproduction of this article (other than one copy for personal reference) must be cleared through the AP Permissions Desk.
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, Elton John AIDS Foundation, National Library of Medicine, Pacific Life Foundation, and donations from users like you.
Always watch for outdated information. This article first appeared in 1985. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 1985. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .